Global Nocturnal Leg Cramps Treatment Market
Tamaño del mercado en miles de millones de dólares
Tasa de crecimiento anual compuesta (CAGR) : %
Período de pronóstico |
2022 –2029 |
Tamaño del mercado (año base) |
USD 364.00 Billion |
Tamaño del mercado (año de pronóstico) |
USD 658.91 Billion |
Tasa de crecimiento anual compuesta (CAGR) |
|
Jugadoras de los principales mercados |
Mercado mundial de tratamiento de calambres nocturnos en las piernas, por clase de fármaco (bloqueadores de los canales de calcio, antiinflamatorios no esteroides (AINE), otros), vía de administración (oral, tópica, otras), forma farmacéutica (comprimidos, ungüentos, geles, otros), diagnóstico (examen físico, análisis de sangre, otros), usuarios finales (hospitales, clínicas especializadas, atención domiciliaria, otros), canal de distribución (farmacia hospitalaria, farmacia minorista, farmacia en línea, otros): tendencias de la industria y pronóstico hasta 2029
Análisis y tamaño del mercado
Los calambres nocturnos en las piernas afectan hasta al 60% de los adultos. La rigidez dolorosa y recurrente de los músculos de la pantorrilla es común y puede causar insomnio severo. El mecanismo específico es incierto, pero el agotamiento muscular y el mal funcionamiento de los nervios tienen más probabilidades de inducir calambres que los trastornos electrolíticos u otros. La enfermedad vascular, la estenosis del canal lumbar, la cirrosis, la hemodiálisis, el embarazo y otros trastornos médicos están relacionados con los calambres nocturnos en las piernas. El hierro sacarosa intravenoso, los estrógenos conjugados, el raloxifeno, el naproxeno y la teriparatida son medicamentos que están estrechamente relacionados con los calambres en las piernas. Una historia clínica y un examen físico suelen ser suficientes para distinguir los calambres nocturnos en las piernas de otros trastornos como el síndrome de piernas inquietas, la claudicación, la miositis y la neuropatía periférica.
Data Bridge Market Research analiza que el mercado de tratamiento de calambres nocturnos en las piernas se valoró en USD 364 millones en 2021 y se espera que alcance los USD 658,91 millones para 2029, registrando una CAGR del 7,70% durante el período de pronóstico de 2022 a 2029. El informe de mercado curado por el equipo de Data Bridge Market Research incluye un análisis de expertos en profundidad, epidemiología del paciente, análisis de la cartera, análisis de precios y marco regulatorio.
Definición de mercado
Los calambres en las piernas que se producen por la noche se caracterizan por una sensación de tirantez y nudos en las piernas. Durante la noche, se producen espasmos dolorosos e involuntarios en la pantorrilla o los muslos. La falta de actividad física, estar de pie durante mucho tiempo o el acortamiento de los tendones son las causas más comunes. Pueden durar desde unos segundos hasta unos minutos. Si el calambre es intenso, el músculo puede doler durante días.
Alcance del informe y segmentación del mercado
Métrica del informe |
Detalles |
Período de pronóstico |
2022 a 2029 |
Año base |
2021 |
Años históricos |
2020 (Personalizable para 2019 - 2014) |
Unidades cuantitativas |
Ingresos en millones de USD, volúmenes en unidades, precios en USD |
Segmentos cubiertos |
Clase de medicamento (bloqueadores de los canales de calcio, antiinflamatorios no esteroides (AINE), otros), vía de administración (oral, tópica, otras), forma farmacéutica (comprimidos, ungüentos, geles, otros), diagnóstico (examen físico, análisis de sangre, otros), usuarios finales (hospitales, clínicas especializadas, atención domiciliaria, otros), canal de distribución (farmacia hospitalaria, farmacia minorista, farmacia en línea, otros) |
Países cubiertos |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America |
Market Players Covered |
F. Hoffmann-La Roche Ltd. (Switzerland), Mylan N.V. (US), Teva Pharmaceutical Industries Ltd.(Israel), Sanofi (France), Pfizer Inc. (US), GlaxoSmithKline plc (UK), Novartis AG (Switzerland), Zydus Cadila (India), Boehringer Ingelheim International GmbH. (Germany), Apotex Inc. (Canada), AstraZeneca (UK), Horizon Therapeutics PLC (Ireland), Johnson & Johnson (US), Bayer AG (Germany), Perrigo Company plc (Ireland), Tolmar Pharmaceuticals, Inc. (US), Reckitt Benckiser Group PLC (UK), Sun Pharmaceutical Industries Ltd. (India), Assertio Therapeutics, Inc. (US), DAIICHI SANKYO COMPANY, LIMITED (Japan) |
Market Opportunities |
|
Nocturnal Leg Cramps Treatment Market Dynamics
Drivers
- Increasing prevalence of nocturnal leg cramps
The rising prevalence of nocturnal leg cramps is estimated to enhance the nocturnal leg cramps treatment market's growth. Leg cramps throughout the night are reported by 50 to 60 percent of adults and about 7% of youngsters. Women are slightly more likely to have them, and their prevalence rises with age.
- Increasing investment for healthcare infrastructure
Another significant factor influencing the growth rate of nocturnal leg cramps treatment market is the rising healthcare expenditure which helps in improving its infrastructure. Also, various government organizations aims to improve the healthcare infrastructure by increasing funding and this will further influence the market dynamics.
- Growing number of geriatric population
The surging geriatric population is estimated to enhance the market's expansion during the forecast period of 2022-2029. According to the World Health Organization (WHO), the worldwide geriatric population, which was estimated to be over 524 million in 2010, is expected to increase to nearly 2 billion by 2050. Due to their compromised immune systems, geriatrics are more susceptible to get nocturnal leg cramps treatment, further estimated to enhance the market's growth rate.
Furthermore, rising initiatives by public and private organizations to spread awareness will expand the nocturnal leg cramps treatment market. Additionally, rise in focuses on management of the nocturnal leg cramps and sedentary lifestyle of people will result in the expansion of nocturnal leg cramps treatment market.
Opportunities
- Increase in the number of research and development activities
Moreover, the market's growth is fueled by an increase in the number of research and development activities. This will provide beneficial opportunities for the nocturnal leg cramps treatment market growth. Along with this, rising drug approvals and launches will further propel the market's growth rate.
Moreover, rising investment for the development of advanced technologies and increase in the number of emerging markets will further provide beneficial opportunities for the nocturnal leg cramps treatment market growth during the forecast period.
Restraints/Challenges
On the other hand, high cost high cost associated with the treatment will obstruct the growth rate of market. Limited primary care services and lack of healthcare infrastructure in developing economies will challenge the nocturnal leg cramps treatment market. Additionally, strict regulatory policies and lack of awareness among people will restrain and further impede the growth rate of the market during the forecast period of 2022-2029.
This nocturnal leg cramps treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the nocturnal leg cramps treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Patient Epidemiology Analysis
Nocturnal leg are found in 40% of people over the age of 50 in the general population, grow in frequency with age, have no sex preference, and are linked to sleep disturbances and ill health. Around 7% of children and adolescents have experienced nocturnal leg cramps. The peak age of occurrence in this cohort was 16 to 18 years old, with no instances reported in children under eight. In most cases, nocturnal leg cramps in children are harmless, self-limiting, and uncommon.
Nocturnal leg cramps treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
COVID-19 Impact on Nocturnal Leg Cramps Treatment Market
Over the projected period, the nocturnal leg cramps treatment market was expected to be constrained by the COVID-19 outbreak. Since its emergence in December 2019, the COVID-19 virus has spread to nearly every country on the planet, prompting the World Health Organization (WHO) to declare it a public health emergency. COVID-19, a new coronavirus, was identified as the causal agent in the pneumonia cases. This virus spread quickly over the world, killing a large number of people. COVID-19 was labelled a global pandemic by the World Health Organization (WHO) in March 2020, and rigorous measures to prevent the disease's spread were recommended. Since then, the pandemic has delayed the expansion of the healthcare sector and disrupted the supply chain. Furthermore, governments in a number of nations had imposed nationwide lockdowns in order to halt the spread of COVID-19. Similarly, healthcare organizations in numerous nations throughout the world were having difficulty continuing their supply chain activities. The nocturnal leg cramps treatment market was hampered by the supply chain slowness.
Global Nocturnal Leg Cramps Treatment Market Scope
The nocturnal leg cramps treatment market is segmented on the basis of drug class, diagnosis, dosage form, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Drug Class
- Calcium Channel Blockers
- Nonsteroidal Anti-Inflammatory (NSAID)
- Others
Diagnosis
- Physical Examination
- Blood Tests
- Others
Dosage Form
- Tablets
- Ointments
- Gels
- Others
Route of Administration
- Oral
- Topical
- Others
End-Users
- Hospitals
- Specialty Clinics
- Homecare
- Others
Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Others
Nocturnal Leg Cramps Treatment Market Regional Analysis/Insights
The nocturnal leg cramps treatment market is analysed and market size insights and trends are provided by country, drug class, diagnosis, dosage form, route of administration, end-users and distribution channel as referenced above.
The countries covered in the nocturnal leg cramps treatment market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
North America dominates the nocturnal leg cramps treatment market because of the growing prevalence of sedentary lifestyles in this region. Additionally, rising healthcare expenditure along with the availability of treatment options will further propel the market's growth rate in this region.
Asia-Pacific are expected to grow during the forecast period of 2022 to 2029 due to presence of major generic pharmaceuticals companies in this region. Also, the development of healthcare infrastructure will further propel themarket's growth rate in this region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Nocturnal Leg Cramps Treatment Market Share Analysis
The Nocturnal leg cramps treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to nocturnal leg cramps treatment market.
Some of the major players operating in the nocturnal leg cramps treatment market are:
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Mylan N.V. (US)
- Teva Pharmaceutical Industries Ltd.(Israel)
- Sanofi (France), Pfizer Inc. (US)
- GlaxoSmithKline plc (UK)
- Novartis AG (Switzerland)
- Zydus Cadila (India)
- Boehringer Ingelheim International GmbH. (Germany)
- Apotex Inc. (Canada)
- AstraZeneca (UK)
- Horizon Therapeutics PLC (Ireland)
- Johnson & Johnson (US)
- Bayer AG (Germany)
- Perrigo Company plc (Ireland)
- Tolmar Pharmaceuticals, Inc. (US)
- Reckitt Benckiser Group PLC (Reino Unido)
- Industrias farmacéuticas Sun Ltd. (India)
- Assertio Therapeutics, Inc. (EE. UU.)
- DAIICHI SANKYO COMPANY, LIMITED (Japón)
SKU-
Obtenga acceso en línea al informe sobre la primera nube de inteligencia de mercado del mundo
- Panel de análisis de datos interactivo
- Panel de análisis de empresas para oportunidades con alto potencial de crecimiento
- Acceso de analista de investigación para personalización y consultas
- Análisis de la competencia con panel interactivo
- Últimas noticias, actualizaciones y análisis de tendencias
- Aproveche el poder del análisis de referencia para un seguimiento integral de la competencia
Metodología de investigación
La recopilación de datos y el análisis del año base se realizan utilizando módulos de recopilación de datos con muestras de gran tamaño. La etapa incluye la obtención de información de mercado o datos relacionados a través de varias fuentes y estrategias. Incluye el examen y la planificación de todos los datos adquiridos del pasado con antelación. Asimismo, abarca el examen de las inconsistencias de información observadas en diferentes fuentes de información. Los datos de mercado se analizan y estiman utilizando modelos estadísticos y coherentes de mercado. Además, el análisis de la participación de mercado y el análisis de tendencias clave son los principales factores de éxito en el informe de mercado. Para obtener más información, solicite una llamada de un analista o envíe su consulta.
La metodología de investigación clave utilizada por el equipo de investigación de DBMR es la triangulación de datos, que implica la extracción de datos, el análisis del impacto de las variables de datos en el mercado y la validación primaria (experto en la industria). Los modelos de datos incluyen cuadrícula de posicionamiento de proveedores, análisis de línea de tiempo de mercado, descripción general y guía del mercado, cuadrícula de posicionamiento de la empresa, análisis de patentes, análisis de precios, análisis de participación de mercado de la empresa, estándares de medición, análisis global versus regional y de participación de proveedores. Para obtener más información sobre la metodología de investigación, envíe una consulta para hablar con nuestros expertos de la industria.
Personalización disponible
Data Bridge Market Research es líder en investigación formativa avanzada. Nos enorgullecemos de brindar servicios a nuestros clientes existentes y nuevos con datos y análisis que coinciden y se adaptan a sus objetivos. El informe se puede personalizar para incluir análisis de tendencias de precios de marcas objetivo, comprensión del mercado de países adicionales (solicite la lista de países), datos de resultados de ensayos clínicos, revisión de literatura, análisis de mercado renovado y base de productos. El análisis de mercado de competidores objetivo se puede analizar desde análisis basados en tecnología hasta estrategias de cartera de mercado. Podemos agregar tantos competidores sobre los que necesite datos en el formato y estilo de datos que esté buscando. Nuestro equipo de analistas también puede proporcionarle datos en archivos de Excel sin procesar, tablas dinámicas (libro de datos) o puede ayudarlo a crear presentaciones a partir de los conjuntos de datos disponibles en el informe.